List view / Grid view
13 December 2016 | By Alex Pye and Mark Brewer, Life Sciences analysts, finnCap
Threats to immediately end Obamacare? Import cheaper drugs from overseas? Analysts Alex Pye and Mark Brewer look to the facts for Trump's pharma impact...
The beauty of the diversity of organic life stems from the ability of certain organisms to thrive in hostile and extreme climatic and environmental conditions where most normal life systems cannot survive1 . These extraordinary, microscopic forms have the power to persist more strongly than large macroscopic creatures2 . Most…
Plants that have known medicinal properties are plentiful in Africa, and primary healthcare in the developing world has, since ancient times, relied heavily on their cultivation and use. Increasingly, too, the uses and effects of medicinal plants are becoming of interest globally.
Quality by Design (QbD) precepts provide opportunities for enhancing efficiencies and reducing costs, especially for generic products. Over 80% of prescriptions dispensed in the United States in 2012 utilised generic dosage forms and it is unlikely that this proportion will increase to any extent because fewer innovative drugs are set…
Spray drying is a proven, flexible and scalable process used within the pharmaceutical industry to address a wide range of formulation and drug delivery challenges. Its versatility has been proven through applications to both small chemical and biopharmaceutical drugs for product delivery via multiple routes of administration.
The life sciences industry is dynamic and as we move towards 2020 and beyond, associated technologies will continue to converge. The forthcoming political, socio-economic and scientific era will throw up challenges, however, with these challenges will come great opportunities. As times change, pharmaceutical companies will need to employ innovative strategies…
12 December 2016 | By Rosalind Connor, Partner, ARC Pensions Law
Rosalind Connor, a Partner at ARC Pensions Law, warns of the danger of a sustainable R+D industry due to global changes in pension law...
5 December 2016 | By Niamh Louise Marriott, Digital Editor
P is for Psoriasis - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
2 December 2016 | By Niamh Louise Marriott, Digital Editor
O is for Obesity - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
Embarrassing Bodies' Dr Christian Jessen talks debunking the stigma surround this pandemic disease and explains why it's OK if we don't find a cure...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
N is for Nivolumab - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
30 November 2016 | By Niamh Louise Marriott, Digital Editor
M is for MRSA - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
29 November 2016 | By Niamh Louise Marriott, Digital Editor
L is for Lab Automation - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
28 November 2016 | By Niamh Louise Marriott, Digital Editor
K is for Kidney - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
25 November 2016 | By Niamh Louise Marriott, Digital Content Producer
J is for Joint Pain - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in this chronic joint pain research...
